ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
28 announcements with these filters
Bhavina J Dholariya, an immediate relative of an insider, sold equity shares of PI Industries Ltd. The market sale was valued at ₹0.12 Crore.
PI Industries received registration for its indigenously developed insecticide, 'Pioxaniliprole' (branded 'Pioxazon'), marking a key milestone in its agricultural innovation journey.
Designated person Jayesh Dholariya disclosed the sale of 3,000 equity shares via gift, totaling approximately Rs. 0.75 Crore.
PI Industries held its 79th Annual General Meeting on August 14, 2026. Shareholders approved all nine agenda items, including financial statements and dividend payments.
PI Industries Q1 FY27 results show resilience amidst global agrochemical headwinds, maintaining healthy EBITDA margins at 22% despite revenue softness. Management remains optimistic about a second-half recovery driven by domestic monsoon improvement and new product scale-ups.
PI Industries Q1 FY27 consolidated revenue fell 10% to ₹17,023 Mn, with EBITDA down 29% and PAT down 39% due to global agrochemical headwinds and cyclical disruptions.
PI Industries will incorporate 'PI Foundation' as a Section 8 company for CSR activities. The company will invest Rs. 0.01 Crore in cash for the shares.
PI Industries Ltd reported revenue from operations of ₹1,702 Cr (-10.4% YoY) and net profit of ₹244.2 Cr (-39.0% YoY) for Q1 FY27.
PI Industries Ltd has scheduled a Board Meeting for August 11, 2026, to consider and approve the unaudited standalone and consolidated financial results.
PI Industries filed its quarterly shareholding pattern for the period ended June 30, 2026. The filing includes a compliance note regarding prior promoter trust transfers.
PI Industries Ltd submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report includes general disclosures and sustainability metrics.
PI Industries has submitted its Integrated Annual Report for FY 2025-26. The company convened its 79th AGM for August 14, 2026, with a record date of August 7.
PI Industries scheduled its 79th AGM for August 14, 2026. The company fixed August 7, 2026, as the record date for a Rs. 10 dividend.
PI Industries converted Rs.1,000 Crore of OFCDs into equity shares of its subsidiary, PI Health Sciences. This internal restructuring strengthens the consolidated balance sheet.
PI Industries submitted its Annual Secretarial Compliance Report for FY2026. The report confirms full regulatory compliance with no observations or penalties recorded.
PI Industries delivered FY26 revenue of ₹67,137M with 25% EBITDA margins. Management transitioned to an innovator-led model with the launch of its first homegrown NCE, Pioxaniliprole.
PI Industries delivered a resilient FY26 despite a global agrochemical downcycle. Management is pivoting toward life sciences and electronic chemicals to de-risk from their single-molecule dependency and agrochemical volatility.
PI Industries reported FY26 revenue of ₹67,137 Mn, down 16% YoY, and PAT of ₹13,208 Mn, down 20%, amid a global agrochemical downcycle.
PI Industries reported a challenging Q4FY26 with revenue and PAT down 12% and 39% respectively due to global agrochemical contraction, while maintaining healthy 58% gross margins.
PI Industries announced major leadership changes, including appointing Dr. Marco Busch and Dr. Atul Kumar Gupta. These strategic board realignments aim to strengthen research and operations.
PI Industries recommended a final dividend of Rs. 10 per equity share for FY 2025-26. The record date will be announced separately for shareholder approval.
PI Industries updated its authorized Key Managerial Personnel for determining event materiality under SEBI regulations. This routine administrative filing ensures compliance with corporate disclosure standards.
PI Industries Ltd reported revenue from operations of ₹1,565 Cr (-12.4% YoY) and net profit of ₹200.2 Cr (-39.4% YoY) for Q4 FY26.
PI Industries approved audited FY26 results and recommended a ₹10 per share final dividend. Consolidated annual revenue reached ₹6,713.7 Crore with ₹1,320.8 Crore profit.
PI Industries scheduled a board meeting for May 19, 2026, to approve fiscal 2026 financial results. Directors will also consider recommending a final dividend.
Rcane Family Trust, a promoter group entity of PI Industries Ltd, submitted an Independent Auditor's Certificate confirming compliance with SEBI Exemption Order conditions for FY 2025-26. The filing is a routine regulatory requirement under SEBI (SAST) Regulations.
Domane Family Trust submitted an Independent Auditor's Certificate for PI Industries Ltd, confirming compliance with SEBI's Exemption Order dated August 14, 2024. The certificate covers the financial year ended March 31, 2026, as required under SEBI SAST Regulations. This is a routine regulatory filing verifying adherence to exemption conditions.
PI Industries Ltd submitted its quarterly certificate under SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The report confirms that share certificates received for dematerialisation were processed and the depositories' names were updated in the register of members within prescribed timelines.